- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
Chuangyuan Biological has obtained another national invention patent authorization related to postbiotics research.
Recently, the invention patent certificate for the "Preparation Method and Application of Active Ingredients of Postbiotics Powder from Lactobacillus casei IOB413" (Patent No.: ZL 202311302088.8), independently developed and applied by Tianjin Chuangyuan Biotechnology Co., Ltd., was issued by the National Intellectual Property Administration.

This invention provides a preparation method and application for the active ingredients of postbiotics powder from Lactobacillus casei IOB413. The active substances obtained by this method have a good inhibitory and killing effect on Helicobacter pylori and Salmonella enteritidis, while having no significant impact on the normal flora or probiotics in the intestine at certain dosages. Therefore, compared to commonly used antibiotics, this active product has stronger selectivity and fewer side effects, showing good efficacy in treating gastrointestinal diseases such as Helicobacter pylori infection, Salmonella enteritidis infection, and Staphylococcus aureus infection.

Related News